Kristin Begley, PharmD

Kristin Begley, PharmD

Chief Growth Officer
Capital Rx

Kristin Begley, PharmD is the Chief Growth Officer at Capital Rx and an industry leader in health information technology, pharmaceutical supply chain and value based care focusing on innovative solutions and software. Today, Capital Rx is the fastest-growing healthcare company in the United States and built around the mission of changing the way prescription drugs are priced and patients are serviced. A health technology company daring to reimagine the pharmacy benefits industry, Capital Rx is executing on that mission through its Clearinghouse Model® - the first equitable framework for drug pricing that sits within the enterprise pharmacy platform, JUDI™, connecting every aspect of the pharmacy ecosystem in one platform, enabling patient engagement and increasing efficiency to achieve the highest standards of clinical care.

Prior to joining Capital Rx, Kristin served as Chief Commercial Officer at Wildflower Health, a digital-enablement care company that specializes in virtual and value-based care for payers, providers and patients. Kristin was a founder and served as Chief Pharmacy Officer at Truveris, a health technology company shining a light on the pharmaceutical supply chain black box. During her time at Truveris, Kristin led the company through a prolonged period of exponential growth. She helped build and deploy their analytical technology platform to drive efficiency in the pharmacy benefit management process for payers, advisors, and consumers. Earlier in her career she worked at Towers Perrin and led Hewitt's National Pharmacy Practice, where she managed pharmacy benefit strategy for Fortune 500 companies. She completed her residency in managed care at the Managed Care Institute and graduated from Samford University McWhorter School of Pharmacy.

All Sessions by Kristin Begley, PharmD

Thinc Main Agenda Monday AM May 23, 2022
10:35 am - 11:20 am

Market Insight: PBM 2.0: Taming the Prescription Drug Beast and Driving a Paradigm Shift with Alignment and Technology

The status quo PBM financial model and legacy technology platforms are failing the healthcare system and are in direct conflict with future state Value-Based Contracting models. New technology has entered the PBM ecosystem changing how members are serviced, drugs are priced and taming the runaway train of prescription drug costs.

Ecosystem stakeholders detail their experience with this next-generation PBM platform and financial framework that has created unprecedented alignment, value, and member experience while also providing prescription drug predictability and pricing equity.

Learn how new technology connects every aspect of the pharmacy ecosystem in one platform, enabling patient engagement and increasing efficiency to achieve the highest standards of clinical care. This panel will bring together healthcare stakeholders to provide the employer, payer, and provider perspectives on:

  • The impetus for building the only commercially available single ledger NADAC based PBM model and discussing the importance of alignment in drug pricing for patients, payers, and providers
  • How the newest PBM platform produces administrative efficiency while optimizing cost, member experience, and equity
  • How this next-generation PBM model provides employers what they really want around predictability in prescription drug spend and it is critical to future value-based contracts as our healthcare system evolves into outcomes-based contracting